TrialInternational journal of hematology2009

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Katsuto Takenaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.